BioNTech announces first patient dosed in Phase 2 clinical trial of mRNA-based BNT111 in patients with advanced melanoma

BioNTech SE (NASDAQ: BNTX, “BioNTech” or “the Company”), announced that the first patient has been treated in its BNT111 Phase 2 cancer vaccine trial (2020-002195-12; NCT04526899). The study is evaluating the Company’s therapeutic cancer vaccine candidate BNT111 in combination with Libtayo® (cemiplimab) in patients with anti-PD1-refractory/relapsed unresectable Stage III or IV melanoma. BNT111 is the […]

Continue Reading

AHA News: Should Rare Cases of Heart Inflammation Put Your COVID-19 Vaccine Plans on Hold?

MONDAY, June 21, 2021 (American Heart Association News) — A possible link between some COVID-19 vaccines and heart inflammation bears close monitoring, but it’s no reason for parents or their teenage children to avoid vaccination. That’s what researchers are saying after several reports of the inflammation in teens and adults who had been vaccinated recently. […]

Continue Reading

Can Your Blood Pressure Medicine Protect Your Memory?

By Amy Norton HealthDay Reporter MONDAY, June 21, 2021 — Older adults who use certain blood pressure drugs may retain more of their memory skills as they age, a new study suggests. Researchers found the benefit among older people taking medications that are allowed past the “blood-brain barrier,” which is a border of specialized cells […]

Continue Reading